MENU

Stephanie E. Weiss Honored as Fellow of ASTRO

July 17, 2018

Stephanie E. Weiss, MD, FASTROStephanie E. Weiss, MD, FASTRO

PHILADELPHIA (July 17, 2018) – Stephanie E. Weiss, MD, chief of the Division of Neurologic Oncology at Fox Chase Cancer Center, will be honored as a fellow of the American Society for Radiation Oncology (ASTRO) at the organization’s 60th annual meeting on October 23 in San Antonio, Texas.

The ASTRO Fellows Program honors radiation oncologists who have made significant contributions to the field, and who have been active members of ASTRO for at least 15 years and given the equivalent of 10 years of service to the organization. Weiss is a past chair of the central nervous system track of ASTRO’s Scientific Committee.

Since joining Fox Chase in 2012 as an attending physician and associate professor, Weiss has been instrumental in the development of the brain tumor service. Her clinical research activities focus on developing and assessing new treatment protocols that provide better outcomes for patients.

Among several prior honors, Weiss appears in America’s Top Doctors® 2017, and she was most recently recognized inPhiladelphia Magazine’s Top Doctors. Weiss is a past recipient of the STAR Award for Outstanding Physician from Upstate Medical University.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

 

For more information, call 888-369-2427

Connect with Fox Chase